Background The integration of artificial intelligence (AI) into critical care offers significant potential to enhance early diagnosis, predict patient deterioration, personalise treatment and inform ...

Rationale Pulmonary rehabilitation (PR) is an effective, key standard treatment for people with COPD. Nevertheless, low participant uptake, insufficient attendance and high drop-out rates are reported ...

Chronic cough (CC) is common, predominantly affecting middle-aged females. Sufferers experience significantly impaired quality of life (QoL). Cough is associated with increased healthcare costs.

Rationale Advance care planning (ACP) is uncommon in patients with chronic obstructive pulmonary disease (COPD). Objectives To assess whether a nurse-led ACP-intervention can improve quality of ...

Correspondence to Professor Sailesh Kotecha, Department of Child Health, Cardiff University School of Medicine, Cardiff, CF14 4XN, UK; kotechas{at}cardiff.ac.uk Rationale Increased outdoor air ...

Rationale While cross-sectional studies have shown associations between certain occupational exposures and lower levels of lung function, there was little evidence from population-based studies with ...

Introduction Sialorrhoea is a debilitating symptom in neurological disease and there is a growing literature for the use of intrasalivary Botulinum Toxin (botox) injections in its management. The ...

State University of New York - Health Science Center at Brooklyn & Kings County Hospital Center, Brooklyn, NY 11203, USA Correspondence to: Dr L S Efferen, Department of Medicine, Long Island Jewish ...

1 Real World Data Science, Medical Evidence, BioPharmaceuticals Medical, AstraZeneca, Cambridge, UK 2 Respiratory Evidence Strategy, BioPharmaceuticals Medical, AstraZeneca, Cambridge, UK 3 Research ...

COPD is set to become the third leading cause of death globally by 2023. To date, we have no significant disease modifying therapies. COPD patients experience chronic inflammation and defective innate ...

Introduction and Objectives The harms of hyperoxia are well recognised in COPD, with recommended peripheral oxygen saturations (SpO2) of 88–92%. Despite this, there is ongoing harm from excessive ...